470 related articles for article (PubMed ID: 10600607)
1. Naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection.
Nicholls PK; Klaunberg BA; Moore RA; Santos EB; Parry NR; Gough GW; Stanley MA
Virology; 1999 Dec; 265(2):365-74. PubMed ID: 10600607
[TBL] [Abstract][Full Text] [Related]
2. Spontaneously regressing oral papillomas induce systemic antibodies that neutralize canine oral papillomavirus.
Ghim S; Newsome J; Bell J; Sundberg JP; Schlegel R; Jenson AB
Exp Mol Pathol; 2000 Jun; 68(3):147-51. PubMed ID: 10816383
[TBL] [Abstract][Full Text] [Related]
3. Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ lymphocytes.
Nicholls PK; Moore PF; Anderson DM; Moore RA; Parry NR; Gough GW; Stanley MA
Virology; 2001 Apr; 283(1):31-9. PubMed ID: 11312659
[TBL] [Abstract][Full Text] [Related]
4. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.
Suzich JA; Ghim SJ; Palmer-Hill FJ; White WI; Tamura JK; Bell JA; Newsome JA; Jenson AB; Schlegel R
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11553-7. PubMed ID: 8524802
[TBL] [Abstract][Full Text] [Related]
5. Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization.
Kirnbauer R; Chandrachud LM; O'Neil BW; Wagner ER; Grindlay GJ; Armstrong A; McGarvie GM; Schiller JT; Lowy DR; Campo MS
Virology; 1996 May; 219(1):37-44. PubMed ID: 8623552
[TBL] [Abstract][Full Text] [Related]
6. Canine papillomavirus--A centenary review.
Nicholls PK; Stanley MA
J Comp Pathol; 1999 Apr; 120(3):219-33. PubMed ID: 10213667
[No Abstract] [Full Text] [Related]
7. Involvement of canine oral papillomavirus in generalized oral and cutaneous verrucosis in a Chinese Shar Pei dog.
Sundberg JP; Smith EK; Herron AJ; Jenson AB; Burk RD; Van Ranst M
Vet Pathol; 1994 Mar; 31(2):183-7. PubMed ID: 8203080
[TBL] [Abstract][Full Text] [Related]
8. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
9. Cell-mediated immune responses to COPV early proteins.
Jain S; Moore RA; Anderson DM; Gough GW; Stanley MA
Virology; 2006 Dec 5-20; 356(1-2):23-34. PubMed ID: 16949120
[TBL] [Abstract][Full Text] [Related]
10. The immunology of animal papillomaviruses.
Nicholls PK; Stanley MA
Vet Immunol Immunopathol; 2000 Feb; 73(2):101-27. PubMed ID: 10690928
[TBL] [Abstract][Full Text] [Related]
11. Protection of beagle dogs from mucosal challenge with canine oral papillomavirus by immunization with recombinant adenoviruses expressing codon-optimized early genes.
Johnston KB; Monteiro JM; Schultz LD; Chen L; Wang F; Ausensi VA; Dell EC; Santos EB; Moore RA; Palker TJ; Stanley MA; Jansen KU
Virology; 2005 Jun; 336(2):208-18. PubMed ID: 15892962
[TBL] [Abstract][Full Text] [Related]
12. Antibody titres against canine papillomavirus 1 peak around clinical regression in naturally occurring oral papillomatosis.
Sancak A; Favrot C; Geisseler MD; Müller M; Lange CE
Vet Dermatol; 2015 Feb; 26(1):57-9, e19-20. PubMed ID: 25496468
[TBL] [Abstract][Full Text] [Related]
13. Viable adenovirus vaccine prototypes: high-level production of a papillomavirus capsid antigen from the major late transcriptional unit.
Berg M; Difatta J; Hoiczyk E; Schlegel R; Ketner G
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4590-5. PubMed ID: 15767581
[TBL] [Abstract][Full Text] [Related]
14. Intraepithelial DNA immunisation with a plasmid encoding a codon optimised COPV E1 gene sequence, but not the wild-type gene sequence completely protects against mucosal challenge with infectious COPV in beagles.
Moore RA; Santos EB; Nicholls PK; White KL; Anderson DM; Lloyd A; Topley P; Romanos M; Thomsen L; Parmar V; Walcott S; Gough GW; Stanley MA
Virology; 2002 Dec; 304(2):451-9. PubMed ID: 12504584
[TBL] [Abstract][Full Text] [Related]
15. Do manatees hold the key to understanding papillomaviruses?
Kuehn BM
J Am Vet Med Assoc; 2002 Nov; 221(9):1240-1. PubMed ID: 12418685
[No Abstract] [Full Text] [Related]
16. Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice.
Revaz V; Benyacoub J; Kast WM; Schiller JT; De Grandi P; Nardelli-Haefliger D
Virology; 2001 Jan; 279(1):354-60. PubMed ID: 11145916
[TBL] [Abstract][Full Text] [Related]
17. Digital papillomatosis in a confined Beagle.
Debey BM; Bagladi-Swanson M; Kapil S; Oehme FW
J Vet Diagn Invest; 2001 Jul; 13(4):346-8. PubMed ID: 11478609
[TBL] [Abstract][Full Text] [Related]
18. Canine inverted papillomas associated with DNA of four different papillomaviruses.
Lange CE; Tobler K; Brandes K; Breithardt K; Ordeix L; Von Bomhard W; Favrot C
Vet Dermatol; 2010 Jun; 21(3):287-91. PubMed ID: 20042038
[TBL] [Abstract][Full Text] [Related]
19. Canine papillomavirus types 1 and 2 in classical papillomas: High abundance, different morphological associations and frequent co-infections.
Lange CE; Jennings SH; Diallo A; Lyons J
Vet J; 2019 Aug; 250():1-5. PubMed ID: 31383413
[TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of a canine oral papillomavirus.
Sundberg JP; O'Banion MK; Schmidt-Didier E; Reichmann ME
Am J Vet Res; 1986 May; 47(5):1142-4. PubMed ID: 3013052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
